ACA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Arcosa Inc (ACA) is a good buy right now for a Beginner investor with a long-term horizon and $50,000-$100,000 available. The stock shows a constructive technical setup, strong recent business momentum, and favorable analyst sentiment. With the shares trading near support after a 2.55% daily pullback, this looks like a reasonable entry point rather than an extended one. The current data supports buying now, not waiting for a perfect dip.
ACA is in an uptrend based on the bullish moving average structure (SMA_5 > SMA_20 > SMA_200). The MACD histogram remains above zero, which confirms positive momentum, though it is contracting, suggesting the trend is still healthy but not accelerating sharply. RSI_6 at 62.966 is neutral-to-bullish and not overbought. Price at 128.04 is above the pivot at 125.224 and below resistance at R1 132.643, leaving room for upside toward 132.64 and then 137.23 if momentum continues. Overall, the technical picture is bullish and suitable for a long-term entry.
["Q1 2026 adjusted EBITDA grew 10% year over year", "Management raised full-year 2026 revenue guidance to $2.65 billion", "Completed a $450 million barge divestiture, simplifying the business and improving focus", "Expected 2026 adjusted EBITDA of $565 million, supported by strong engineered structures demand", "Secular growth tailwinds in utilities, infrastructure spending, and electricity demand", "Analyst target increases and positive coverage actions reinforce upside sentiment"]
["Recent daily price decline of 2.55%", "Q4 2025 net income and EPS declined sharply year over year", "Rising diesel prices and new steel tariffs may pressure costs", "Hedge funds and insiders are neutral with no notable accumulation trend", "MACD momentum is positive but contracting, implying less near-term acceleration"]
In Q4 2025, Arcosa reported revenue of $716.7 million, up 7.58% year over year, which shows solid top-line growth. Gross margin improved to 22.85%, up 18.09% year over year, indicating better operating efficiency. However, net income fell to $52 million and EPS declined to $1.06, both down sharply year over year, so profitability at the bottom line was weaker in that quarter. The latest quarter season was Q4 2025, and the more recent Q1 2026 update was stronger, with 10% adjusted EBITDA growth and higher revenue guidance.
Analyst sentiment is positive and improving. Barclays raised its price target to $140 from $115 and maintained Overweight, calling the Q1 report strong. Texas Capital initiated with Buy and a $125 target, citing solid revenue growth and margin expansion potential. DA Davidson also raised its target to $125 from $120 and kept Buy after Q4 results. The Street view is constructive: pros include secular infrastructure and utility demand, margin improvement, disciplined capital allocation, and simplification from the barge divestiture. The main cons are cost pressures from diesel and steel tariffs, plus some uncertainty around wind contributions. Overall, Wall Street is bullish on ACA.
